|
|
Press Coverage
Sorting Through Challenges, Opportunities Of Stem Cells
Dec. 29, 2009
| Source: Wall Street Journal Blogs, Venture Capital Dispatch
Striking a cord
Nov. 5, 2009
| Source: Haaretz.com
StemEx(R) Noted As A Reliable Investigational Product Of An Expanded Population Of Stem Cells At Umbilical Cord Blood Symposium In Israel
Nov. 3, 2009
| Source: Medical News Today
איך מפיקים דם טבורי אקסטרה-לארג'?
Nov. 1, 2009
Cellerix to Test Gamida’s Expansion Technologies with Its Stem Cell-Based Drugs
Oct. 21, 2009
| Source: Genetic Engineering News
Cura della leucemia, Careggi partecipa alla ricerca
Oct. 20, 2009
| Source: Il Reporter.it
Phase III Trial of Expanded Umbilical Cord Blood (StemEx®) for Treatment of Hematologic Malignancies Announced
Jun. 16, 2009
| Source: CancerConsultants.com
Hospitals in Spain join Gamida Cell cord blood study
Jun. 4, 2009
| Source: Globes
EU grants Gamida Cell-Teva JV product orphan status
Mar. 11, 2009
| Source: Globes
EU grants orphan status to Teva-Gamida Cell venture's drug
Mar. 11, 2009
| Source: Marketwatch
Blood cancer patient undergoes first stem cell transplant using Israeli-developed StemEx cord blood technique
Nov. 8, 2007
| Source: Israel 21C
Gamida Cell Raises $16 Million in Venture Capital Financing
Sep. 28, 2006
| Source: Venture Capital Reporter
Gamida Completes $16M Round
Sep. 26, 2006
| Source: Red Herring
Profile: Fresh hope for leukaemia sufferers
Jun. 28, 2006
| Source: Financial Times of London
Israeli biotech nears commercial breakthrough in blood stem cells
May. 23, 2004
| Source: The Independent
Small Stem Cells Find Big Backers
Mar. 3, 2004
| Source: Forbes
|
|
